Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-4-21
|
pubmed:abstractText |
A novel butyric acid derivative, pivaloyloxymethyl butyrate, AN-9, was previously shown to be a potent differentiating agent. AN-9 exerts a significant anticancer activity in vitro and in vivo. In all the activities examined, AN-9 was more potent than butyric acid. Here we show that AN-9 and butyric acid induce cell death by apoptosis. Exposure of HL-60 cells to butyric acid and AN-9 decreased cell numbers and induced cell differentiation and the appearance of typical apoptotic features. Induction of apoptosis and/or differentiation by AN-9 and butyric acid was dependent on the concentration and the time of exposure to the drugs. The advantage of AN-9 over butyric acid was further confirmed. Apoptosis induced by AN-9 occurred after a shorter exposure and at lower drug concentrations than that induced by butyric acid. Apoptosis by AN-9 was accompanied by reduction in Bcl-2 expression. Preincubation with antioxidants did not protect HL-60 cells from apoptosis induced by AN-9. HL-60 cells that were induced to differentiate by preincubation with retinoic acid or low AN-9 concentrations were more resistant to apoptosis, induced later by high concentrations of AN-9, than were undifferentiated cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Butyrates,
http://linkedlifedata.com/resource/pubmed/chemical/Butyric Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Butyric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/pivalyloxymethyl butyrate
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0171-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9119880-Antineoplastic Agents,
pubmed-meshheading:9119880-Apoptosis,
pubmed-meshheading:9119880-Butyrates,
pubmed-meshheading:9119880-Butyric Acid,
pubmed-meshheading:9119880-Butyric Acids,
pubmed-meshheading:9119880-Cell Count,
pubmed-meshheading:9119880-Cell Differentiation,
pubmed-meshheading:9119880-Cell Division,
pubmed-meshheading:9119880-DNA, Neoplasm,
pubmed-meshheading:9119880-Gene Expression,
pubmed-meshheading:9119880-Genes, bcl-2,
pubmed-meshheading:9119880-HL-60 Cells,
pubmed-meshheading:9119880-Humans,
pubmed-meshheading:9119880-Proto-Oncogene Proteins c-bcl-2
|
pubmed:year |
1997
|
pubmed:articleTitle |
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
|
pubmed:affiliation |
Division of Hematology, Rabin Medical Center, Petach Tikava, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|